Target
Flavin reductase (NADPH)
Ligand
BDBM50320491
Substrate
n/a
Meas. Tech.
ChEMBL_2153628 (CHEMBL5038175)
Kd
1622±n/a nM
Citation
 Kim, MHa, JHChoi, JKim, BRGapsys, VLee, KOJee, JGChakrabarti, KSde Groot, BLGriesinger, CRyu, KSLee, D Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX? Reductase B as a Novel Thrombocytopenia Therapeutic Target. J Med Chem 65:2548-2557 (2022) [PubMed]  Article 
Target
Name:
Flavin reductase (NADPH)
Synonyms:
1.3.1.24 | 1.5.1.30 | BLVRB | BLVRB_HUMAN | BVR-B | Biliverdin reductase B | Biliverdin-IX beta-reductase | FLR
Type:
PROTEIN
Mol. Mass.:
22123.63
Organism:
Homo sapiens
Description:
ChEMBL_100283
Residue:
206
Sequence:
MAVKKIAIFGATGQTGLTTLAQAVQAGYEVTVLVRDSSRLPSEGPRPAHVVVGDVLQAADVDKTVAGQDAVIVLLGTRNDLSPTTVMSEGARNIVAAMKAHGVDKVVACTSAFLLWDPTKVPPRLQAVTDDHIRMHKVLRESGLKYVAVMPPHIGDQPLTGAYTVTLDGRGPSRVISKHDLGHFMLRCLTTDEYDGHSTYPSHQYQ
  
Inhibitor
Name:
BDBM50320491
Synonyms:
2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID | CHEMBL1164729 | FEBUXOSTAT | US11744839, Compound of formula 5
Type:
Small organic molecule
Emp. Form.:
C16H16N2O3S
Mol. Mass.:
316.375
SMILES:
CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O
Structure:
Search PDB for entries with ligand similarity: